Literature DB >> 33291422

Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review.

Jacques Donnez1,2.   

Abstract

BACKGROUND: The objective of this review is to determine the evidence or, conversely, the absence of evidence regarding the effectiveness of progestogens in treating premenopausal women with uterine fibroids. In particular, the goal is to address recurring questions as to whether they are effective or not for managing symptoms commonly attributed to fibroids.
METHODS: A review of the most relevant papers (n = 63) on the efficacy of progesterone and progestogens as medical therapy for uterine fibroids.
RESULTS: Having reviewed the most significant papers on the relationship between uterine fibroids and progesterone/progestogens, it is clear that there is biochemical, histological and clinical evidence that progesterone and progestogens play a critical role in the pathogenesis of myomas.
CONCLUSION: Since progesterone is already implicated in the pathogenesis of this entity, using progestogens to manage fibroids is like constantly adding fuel to the fire, rendering this treatment ineffective.

Entities:  

Keywords:  GnRH agonist; GnRH antagonist; add-back therapy; heavy menstrual bleeding; progesterone; progestogen; uterine fibroids

Year:  2020        PMID: 33291422      PMCID: PMC7762035          DOI: 10.3390/jcm9123948

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  79 in total

1.  Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT.

Authors:  F Polatti; F Viazzo; R Colleoni; R E Nappi
Journal:  Maturitas       Date:  2000-11-30       Impact factor: 4.342

Review 2.  Clinical practice. Uterine fibroids.

Authors:  Elizabeth A Stewart
Journal:  N Engl J Med       Date:  2015-04-23       Impact factor: 91.245

3.  Comparing Apples to Apples for Fibroids.

Authors:  Elizabeth A Stewart
Journal:  N Engl J Med       Date:  2020-07-30       Impact factor: 91.245

Review 4.  Fibroid growth and medical options for treatment.

Authors:  Nathalie Chabbert-Buffet; Nathalie Esber; Philippe Bouchard
Journal:  Fertil Steril       Date:  2014-09       Impact factor: 7.329

5.  Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3.

Authors:  Donna C Sinclair; Alex Mastroyannis; Hugh S Taylor
Journal:  J Clin Endocrinol Metab       Date:  2010-11-17       Impact factor: 5.958

6.  Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids.

Authors:  Jacques Donnez; Robert Hudecek; Olivier Donnez; Dace Matule; Hans-Joachim Arhendt; Janos Zatik; Zaneta Kasilovskiene; Mihai Cristian Dumitrascu; Hervé Fernandez; David H Barlow; Philippe Bouchard; Bart C J M Fauser; Elke Bestel; Paul Terrill; Ian Osterloh; Ernest Loumaye
Journal:  Fertil Steril       Date:  2014-12-24       Impact factor: 7.329

7.  The management of uterine leiomyomas.

Authors:  George A Vilos; Catherine Allaire; Philippe-Yves Laberge; Nicholas Leyland
Journal:  J Obstet Gynaecol Can       Date:  2015-02

8.  Mitotic activity in uterine leiomyomas during the menstrual cycle.

Authors:  K Kawaguchi; S Fujii; I Konishi; Y Nanbu; H Nonogaki; T Mori
Journal:  Am J Obstet Gynecol       Date:  1989-03       Impact factor: 8.661

Review 9.  Current medical treatment of uterine fibroids.

Authors:  Geum Seon Sohn; SiHyun Cho; Yong Man Kim; Chi-Heum Cho; Mee-Ran Kim; Sa Ra Lee
Journal:  Obstet Gynecol Sci       Date:  2018-02-13

Review 10.  Uterine fibroid management: from the present to the future.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Hum Reprod Update       Date:  2016-07-27       Impact factor: 15.610

View more
  4 in total

Review 1.  Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.

Authors:  Mohamed Ali; Mohamed Raslan; Michał Ciebiera; Kornelia Zaręba; Ayman Al-Hendy
Journal:  Expert Opin Drug Saf       Date:  2021-10-20       Impact factor: 4.250

Review 2.  Epigenomic and enhancer dysregulation in uterine leiomyomas.

Authors:  Oliwia W Mlodawska; Priyanka Saini; J Brandon Parker; Jian-Jun Wei; Serdar E Bulun; Melissa A Simon; Debabrata Chakravarti
Journal:  Hum Reprod Update       Date:  2022-06-30       Impact factor: 17.179

3.  Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma.

Authors:  Saki Tanioka; Ryoko Asano; Reina Wakabayashi; Hiroyuki Hayashi; Hiroyuki Shigeta
Journal:  BMC Womens Health       Date:  2022-08-16       Impact factor: 2.742

Review 4.  Phytoprogestins: Unexplored Food Compounds with Potential Preventive and Therapeutic Effects in Female Diseases.

Authors:  Stefania Greco; Pamela Pellegrino; Alessandro Zannotti; Giovanni Delli Carpini; Andrea Ciavattini; Fernando M Reis; Pasquapina Ciarmela
Journal:  Nutrients       Date:  2021-11-30       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.